McGuire M C, Fields R M, Nyomba B L, Raz I, Bogardus C, Tonks N K, Sommercorn J
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016.
Diabetes. 1991 Jul;40(7):939-42. doi: 10.2337/diab.40.7.939.
Insulin resistance in skeletal muscle may be an expression of the genetic basis of a common form of non-insulin-dependent diabetes mellitus (NIDDM) in humans. Impaired insulin action results from an apparent postreceptor defect in insulin signal transduction that limits the influence of the hormone on various protein serine/threonine kinases and phosphatases that are thought to contribute to the mechanism by which insulin affects intracellular events. The fact that numerous responses to insulin are affected suggests that the cause of insulin resistance involves an early step in insulin action. Therefore, we examined the influence of insulin on protein tyrosine phosphatase (PTPase) activities, which may counteract the protein tyrosine kinase activity of the insulin receptor in skeletal muscle of insulin-sensitive and insulin-resistant humans. Insulin infusion in vivo produced a rapid 25% suppression of soluble-PTPase activity in muscle of insulin-sensitive subjects, but this response was severely impaired in subjects who were insulin resistant. Insulin did not affect PTPase activity in the particulate fraction of muscle from either group, but basal particulate activity was 33% higher in resistant subjects than in sensitive subjects. Either or both of these abnormal characteristics of PTPase activities could be central to the causes of insulin resistance and NIDDM.
骨骼肌中的胰岛素抵抗可能是人类常见的非胰岛素依赖型糖尿病(NIDDM)遗传基础的一种表现。胰岛素作用受损是由胰岛素信号转导中明显的受体后缺陷导致的,这种缺陷限制了激素对各种蛋白质丝氨酸/苏氨酸激酶和磷酸酶的影响,而这些激酶和磷酸酶被认为参与了胰岛素影响细胞内事件的机制。对胰岛素的多种反应受到影响这一事实表明,胰岛素抵抗的原因涉及胰岛素作用的早期步骤。因此,我们研究了胰岛素对蛋白质酪氨酸磷酸酶(PTPase)活性的影响,该酶可能会抵消胰岛素敏感和胰岛素抵抗人群骨骼肌中胰岛素受体的蛋白质酪氨酸激酶活性。体内输注胰岛素可使胰岛素敏感受试者肌肉中的可溶性PTPase活性迅速降低25%,但在胰岛素抵抗受试者中,这种反应严重受损。胰岛素对两组受试者肌肉颗粒部分的PTPase活性均无影响,但抵抗受试者的基础颗粒活性比敏感受试者高33%。PTPase活性的这些异常特征中的一个或两个可能是胰岛素抵抗和NIDDM病因的核心。